| Brand Name | Jakavi |
| Packaging Type | Blister pack |
| Molecule | Ruxolitinib |
| Generic Name | Ruxolitinib 15mg |
| Manufactured By | Novartis India |
| Quantity | 14 tablets in 1 strip |
| Form | Tablets |
| Country of Origin | Switzerland |
| Categories | Oncology |
Jakavi 15mg tablets are used in the treatment of blood cancer. It works by decreasing the number of red blood cells, which is produced by the body. Thereby prevents the cancer cells from growing and multiplying. Jakavi 15mg tablets interfere with the growth of cancer cells and can reduce immune system activity.
When taking Jakavi 15mg tablets, avoid grapefruit and Seville oranges because they can interfere with how the medication works. Limit high-fiber foods, like raw meats, eggs, and seafood, to reduce digestive risks and infections, which can be more challenging with a Jakavi 15mg tablet. Use alcohol sparingly or avoid it completely to prevent interactions that might affect treatment.
After taking Jakavi 15mg tablets generally, some patients may begin to see initial effects within a few weeks of starting treatment, such as a reduction in symptoms or stabilization of blood counts. It can take between 6 - 12 weeks before you start to feel the benefits of your treatment. However, to fully assess its effectiveness in controlling cancer growth and achieving remission, it typically requires several months of continuous treatment. Jakavi 15mg tablets do not work immediately.
Nausea and vomiting Loss of appetite Diarrhea Mouth sores Fatigue
Always talk to your doctor before taking Ruxolitinib 15mg with other medications. This is important because Ruxolitinib 15mg can interact with other drugs, which might change how it works or increase the risk of side effects. Your doctor can help you safely manage all your medications together.
